(Q36344173)

13 August 2017

title

The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy (English)

1 reference

13 August 2017

Francisco M Marty

1

1 reference

13 August 2017

Robert H Rubin

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2006

1 reference

13 August 2017

published in

Transplant International

1 reference

13 August 2017

volume

19

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

2-11

1 reference

The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Infection in the renal transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Infection in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Transplanted infections: donor-to-host transmission with the allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Transmission of West Nile virus from an organ donor to four transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Transmission of rabies virus from an organ donor to four transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Interactions between viruses in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Clinical aspects of CMV infection after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Infection in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00218.X

10.1111/J.1432-2277.2005.00218.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference